Assessment of cell infiltration in myocardial infarction: a dose-dependent study using micrometer-sized iron oxide...

Area of Science:

• Cardiovascular Imaging
• Biomedical Engineering
• Nanotechnology

Background:

• Myocardial infarction (MI) is a major cause of mortality and morbidity.
• Inflammatory cell infiltration is crucial for post-MI cardiac remodeling and repair.
• T2-weighted MRI with iron oxide particles can monitor inflammatory cell migration.

Purpose of the Study:

• To evaluate the efficacy of micrometer-sized iron oxide particles for monitoring inflammatory cell infiltration post-MI using MRI.
• To determine the optimal dose and temporal window for iron oxide-enhanced MRI in tracking inflammatory cells.
• To assess the potential of this technique for evaluating therapeutic interventions.

Main Methods:

• Surgical induction of MI in mice followed by intravenous injection of varying doses of iron oxide particles (1.1-14.5 μg Fe/g).
• Cardiac MRI (T2-weighted) performed at 3, 7, 14, and 21 days post-MI to assess signal attenuation at the infarct site.
• Analysis of dose-dependent signal changes and identification of optimal iron oxide dosage and imaging time points.

Main Results:

• A dose-dependent signal attenuation was observed in the infarct site, with higher iron oxide doses resulting in darker signals.
• An optimal iron oxide dose range of approximately 9.1-14.5 μg Fe/g body weight was identified for effective signal monitoring.
• Specific temporal windows were suggested for optimal detection of iron oxide-labeled inflammatory cell infiltration.

Conclusions:

• Iron oxide-enhanced MRI is a promising technique for monitoring inflammatory cell infiltration after myocardial infarction.
• The study identified optimal iron oxide doses and imaging times for improved diagnostic accuracy.
• This MRI approach holds potential for assessing therapeutic strategies targeting cellular responses in cardiovascular disease.